Physician profile
Arusha Gupta
NPI 1003007816
$3,988.63
in general payments reported to CMS, 2019-2025
23 companies · $723 in 2025
The $723 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $890 · 2020: $401 · 2021: $412 · 2022: $372 · 2023: $661 · 2024: $531 · 2025: $723.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,897 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,896.98 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $481.70 | 2019-2021 | |
| Alcon Vision LLC | $459.78 | 2019-2025 | Clareon, Eysuvis, Unity |
| Sun Pharmaceutical Industries INC. | $430.41 | 2019-2025 | Cequa |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $294.96 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $245.91 | 2022-2025 | Ic-8 Apthera Iol, Envista Mx60 Iol, Miebo |
| Oyster Point Pharma, INC. | $219.19 | 2022-2025 | Tyrvaya, Ryzumvi |
| Novartis Pharmaceuticals Corporation | $204.35 | 2019-2023 | |
| Abbvie INC. | $202.97 | 2022-2023 | |
| Biotissue Holdings INC. | $199.17 | 2023-2025 | |
| Tarsus Pharmaceuticals, INC. | $194.60 | 2024-2025 | Xdemvy |
| Mallinckrodt Hospital Products INC. | $181.82 | 2024-2025 | Acthar |
| Kala Pharmaceuticals, INC. | $140.09 | 2019-2022 | |
| Genentech USA, INC. | $126.88 | 2025 | Susvimo |
| Shire North American Group INC | $122.76 | 2019 | |
| Carl Zeiss Meditec, INC. | $105.00 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $97.27 | 2021-2024 | Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens, Rxsight Injector Handpiece |
| Johnson & Johnson Surgical Vision, INC. | $65.09 | 2019 | |
| Dompe US, INC. | $49.73 | 2019-2025 | Oxervate |
| Thea Pharma INC. | $44.04 | 2023-2024 | Iyuzeh |
| Aerie Pharmaceuticals, INC. | $43.04 | 2019-2021 | |
| Sight Sciences, INC. | $42.29 | 2022-2024 | Omni Surgical System |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Oasis Medical, INC. | $18.18 | 2025 | Oasis Tears |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arusha Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.